Volume | 764,354 |
|
|||||
News | - | ||||||
Day High | 53.98 | Low High |
|||||
Day Low | 52.77 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Globus Medical Inc | GMED | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
53.00 | 52.77 | 53.98 | 53.64 | 53.06 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
13,309 | 764,354 | $ 53.67 | $ 41,019,792 | - | 43.385 - 62.88 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 147,703 | $ 53.64 | USD |
Globus Medical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.26B | 135.37M | - | 1.57B | 122.87M | 0.91 | 59.07 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Globus Medical News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GMED Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 52.22 | 53.98 | 50.87 | 52.01 | 870,302 | 1.42 | 2.72% |
1 Month | 54.69 | 56.00 | 50.87 | 52.89 | 1,073,128 | -1.05 | -1.92% |
3 Months | 51.69 | 57.46 | 50.87 | 53.90 | 1,196,042 | 1.95 | 3.77% |
6 Months | 50.00 | 57.46 | 43.385 | 51.13 | 1,246,633 | 3.64 | 7.28% |
1 Year | 53.06 | 62.88 | 43.385 | 53.52 | 1,360,410 | 0.58 | 1.09% |
3 Years | 60.58 | 84.23 | 43.385 | 60.11 | 897,459 | -6.94 | -11.46% |
5 Years | 48.59 | 84.23 | 33.41 | 56.90 | 813,849 | 5.05 | 10.39% |
Globus Medical Description
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. |